Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Giving chemotherapy and total-body irradiation before a donor peripheral stem cell
transplant helps stop the growth of cancer and abnormal cells and helps stop the patient's
immune system from rejecting the donor's stem cells. When the stem cells from a related
donor, that do not exactly match the patient's blood, are infused into the patient they may
help the patient's bone marrow make stem cells, red blood cells, white blood cells, and
platelets.
PURPOSE: This phase II trial is studying how well giving chemotherapy with or without
radiation therapy followed by donor stem cell transplant works in treating patients with
hematologic cancer.